Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation
Xingyue He(Changchun University of Chinese Medicine), Neil Bence(Takeda (United States))
Cited by 60
Related Papers
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
|Nature Chemical Biology|2017|228
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
|Nature Communications|2019|210
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
|Journal of Medicinal Chemistry|2021|205
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
|Science Translational Medicine|2021|139